
DERMAPHARM
Share · DE000A2GS5D8 · A2GS5D (XFRA)
36,85 EUR
09.06.2025 15:35
Current Prices from DERMAPHARM
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() XETRA |
DMP.DE
|
EUR
|
09.06.2025 15:35
|
36,85 EUR
| 36,90 EUR
-0,14 %
|
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-0,14 % | 4,99 % | -5,99 % | -6,11 % | -3,03 % | -0,27 % | -14,99 % |
Company Profile for DERMAPHARM Share
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
Invested Funds
The following funds have invested in: DERMAPHARM invested:
Fund | Vol. in million 2.268,55 | Percentage (%) 0,26 % |
Company Data
Name DERMAPHARM
Company Dermapharm Holding SE
Website
https://www.dermapharm.de
Primary Exchange
Frankfurt

WKN A2GS5D
ISIN DE000A2GS5D8
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dr. Hans-Georg Feldmeier
Market Capitalization 2 Mrd.
Country Germany
Currency EUR
Employees 3,6 T
Address Lil-Dagover-Ring 7, 82031 Grünwald
IPO Date 2018-04-12
Dividends from 'DERMAPHARM'
Ex-Date | Dividend per Share |
---|---|
28.06.2024 | 0,88 EUR |
06.06.2024 | 0,88 EUR |
15.06.2023 | 1,05 EUR |
02.06.2022 | 2,17 EUR |
24.06.2021 | 0,88 EUR |
18.06.2020 | 0,80 EUR |
05.06.2019 | 0,77 EUR |
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | DMP.F |
XETRA | DMP.DE |
More Shares
Investors who DERMAPHARM hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.